The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells

Blood

Volumn 123, Issue 19, 2014, Pages 2988-2996

  Zhang, Jenny ^a,b   Jima, Dereje ^a   Moffitt, Andrea B ^a   Liu, Qingquan ^a   Czader, Magdalena ^c   Hsi, Eric D ^d   Fedoriw, Yuri ^e   Dunphy, Cherie H ^e   Richards, Kristy L ^e   Gill, Javed I ^f   Sun, Zhen ^a   Love, Cassandra ^a   Scotland, Paula ^a   Lock, Eric ^g   Levy, Shawn ^h   Hsu, David S ^a,b   Dunson, David ^g   Dave, Sandeep S ^a,b,i  

^a DUKE UNIVERSITY   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^g Duke University   (United States)

^h HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

ⁱ DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; ATM PROTEIN; BRG1 PROTEIN; CYCLIN D1; HISTONE H3; MLL2 PROTEIN; NOTCH1 RECEPTOR; POT1 PROTEIN; PROTEIN; PROTEIN P53; RB1 PROTEIN; UNCLASSIFIED DRUG; WHSC1 PROTEIN; CHROMATIN; DNA BINDING PROTEIN; DNA HELICASE; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; MLL2 PROTEIN, HUMAN; NUCLEAR PROTEIN; POT1 PROTEIN, HUMAN; REPRESSOR PROTEIN; RETINOBLASTOMA PROTEIN; SMARCA4 PROTEIN, HUMAN; TELOMERE BINDING PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN; WHSC1 PROTEIN, HUMAN;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BURKITT LYMPHOMA; CELL CYCLE REGULATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA DAMAGE; EPIGENETICS; EXOME; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC DIFFERENCE; GENETIC VARIABILITY; GERMINAL CENTER; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN TISSUE; LARGE CELL LYMPHOMA; MANTLE CELL LYMPHOMA; MEMORY CELL; MUTATION RATE; MUTATIONAL ANALYSIS; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SOMATIC MUTATION; TRANSCRIPTION INITIATION SITE; TUMOR SUPPRESSOR GENE; DNA SEQUENCE; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETICS; GENOMICS; METABOLISM; METHYLATION; MUTATION; PATHOLOGY;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; B-LYMPHOCYTES; BURKITT LYMPHOMA; CHROMATIN; CYCLIN D1; DNA HELICASES; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; EXOME; GENE REGULATORY NETWORKS; GENOMICS; GERMINAL CENTER; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; LYMPHOMA, MANTLE-CELL; METHYLATION; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; SEQUENCE ANALYSIS, DNA; TELOMERE-BINDING PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84903182870     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-07-517177     Document Type: Article

References (48)

1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
2. Kridel R, Meissner B, Rogic S, et al. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood. 2012;119(9):1963-1971.
3. Meissner B, Kridel R, Lim RS, et al. The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma. Blood. 2013;121(16):3161-3164.
4. Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013;45(10):1127-1133.
5. Morin RD, Mendez-Lago M, Mungall AJ, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011;476(7360):298-303.
6. Morin RD, Johnson NA, Severson TM, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet. 2010;42(2):181-185.
7. Béguelin W, Popovic R, Teater M, et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell. 2013;23(5):677-692.
8. Schuster-Böckler B, Lehner B. Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature. 2012;488(7412):504-507.
9. Berger MF, Lawrence MS, Demichelis F, et al. The genomic complexity of primary human prostate cancer. Nature. 2011;470(7333):214-220.
10. Akhtar-Zaidi B, Cowper-Sal-lari R, Corradin O, et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science. 2012;336(6082):736-739.
11. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M; ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57-74.
12. Jima DD, Zhang J, Jacobs C, et al Hematologic Malignancies Research Consortium. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood. 2010;116(23):e118-e127.
13. Zhang J, Grubor V, Love CL, et al. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci USA. 2013;110(4):1398-1403.
14. Zhang J, Jima DD, Jacobs C, et al. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood. 2009;113(19):4586- 4594.
15. Cock PJ, Fields CJ, Goto N, Heuer ML, Rice PM. The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. Nucleic Acids Res. 2010;38(6):1767-1771.
16. McKenna A, Hanna M, Banks E, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297-1303.
17. Love C, Sun Z, Jima D, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012;44(12):1321-1325.
18. Hartmann EM, Campo E, Wright G, et al. Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. Blood. 2010;116(6):953-961.
19. Parmigiani G, Boca S, Lin J, Kinzler KW, Velculescu V, Vogelstein B. Design and analysis issues in genome-wide somatic mutation studies of cancer. Genomics. 2009;93(1):17-21.
20. Li H, Handsaker B, Wysoker A, et al; 1000 Genome Project Data Processing Subgroup. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25(16):2078-2079.
21. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.
22. Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31(3):213-219.
23. Siva N. 1000 Genomes project. Nat Biotechnol. 2008;26(3):256.
24. Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308-311. (Pubitemid 32054478)
25. Yi X, Liang Y, Huerta-Sanchez E, et al. Sequencing of 50 human exomes reveals adaptation to high altitude. Science. 2010;329(5987):75-78.
26. Li Y, Vinckenbosch N, Tian G, et al. Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants. Nat Genet. 2010;42(11):969-972.
27. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26(6):841-842.
28. Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007;318(5853):1108-1113. (Pubitemid 350134889)
29. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10(3):R25.
30. Zhang Y, Liu T, Meyer CA, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9(9):R137.
31. Dave SS, Fu K, Wright GW, et al Lymphoma/Leukemia Molecular Profiling Project. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med. 2006;354(23):2431-2442. (Pubitemid 43855046)
32. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249-264.
33. Bamford S, Dawson E, Forbes S, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer. 2004;91(2):355-358. (Pubitemid 39037083)
34. Lohr JG, Stojanov P, Lawrence MS, et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA. 2012;109(10):3879-3884.
35. Pasqualucci L, Trifonov V, Fabbri G, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet. 2011;43(9):830-837.
36. Richter J, Schlesner M, Hoffmann S, et al ICGC MMML-Seq Project. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet. 2012;44(12):1316-1320.
37. Schmitz R, Young RM, Ceribelli M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012;490(7418):116-120.
38. Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell. 2007;129(4):823-837. (Pubitemid 46802390)
39. Heintzman ND, Stuart RK, Hon G, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet. 2007;39(3):311-318. (Pubitemid 46328487)
40. Beà S, Valdés-Mas R, Navarro A, et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci USA. 2013;110(45):18250-18255.
41. Rahal R, Frick M, Romero R, et al. Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma. Nat Med. 2014;20(1):87-92.
42. Greiner TC, Dasgupta C, Ho VV, et al. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma. Proc Natl Acad Sci USA. 2006;103(7):2352-2357. (Pubitemid 43271673)
43. Garraway LA, Sellers WR. Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer. 2006;6(8):593-602. (Pubitemid 44140858)
44. Ye BH, Cattoretti G, Shen Q, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet. 1997;16(2):161-170.
45. Ye BH, Lo Coco F, Chang CC, et al. Alterations of the BCL-6 gene in diffuse large-cell lymphoma. Curr Top Microbiol Immunol. 1995;194:101-108.
46. Victora GD, Dominguez-Sola D, Holmes AB, Deroubaix S, Dalla-Favera R, Nussenzweig MC. Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood. 2012;120(11):2240-2248.
47. Brock RD. Differential mutation of the betagalactosidase gene of Escherichia coli. Mutat Res. 1971;11(2):181-186.
48. Kim N, Huang SN, Williams JS, et al. Mutagenic processing of ribonucleotides in DNA by yeast topoisomerase I. Science. 2011;332(6037):1561- 1564.